
   <?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 14 Aug 2026 23:10:32 -0400--><rss version="2.0">
    <channel>
        <title>Processa Pharmaceuticals, Inc. (PCSA) SEC Filings</title>
        <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/rss</link>
        <description>Processa Pharmaceuticals, Inc. (PCSA) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/processapharmaceuticals/files/theme/images/logo-sm.png</url>
                <title>Processa Pharmaceuticals, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038334/0001493152-26-038334.pdf</link>
                <pubDate>Fri, 14 Aug 26 16:22:57 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038334/0001493152-26-038334.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001602/0000897069-26-001602.pdf</link>
                <pubDate>Tue, 11 Aug 26 16:26:02 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001602/0000897069-26-001602.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[8-K]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-036032/0001493152-26-036032.pdf</link>
                <pubDate>Tue, 04 Aug 26 17:26:38 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-036032/0001493152-26-036032.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001575202-26-000011/0001575202-26-000011.pdf</link>
                <pubDate>Thu, 30 Jul 26 21:50:24 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001575202-26-000011/0001575202-26-000011.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[3 - Initial statement of beneficial ownership of securities]]></title>
                <description><![CDATA[3]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001575202-26-000009/0001575202-26-000009.pdf</link>
                <pubDate>Thu, 30 Jul 26 21:46:35 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001575202-26-000009/0001575202-26-000009.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[7 Related Documents: 8-K, EX-2.1, EX-3.1, EX-10.1, EX-10.2, EX-99.1, EX-99.2]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-035099/0001493152-26-035099.pdf</link>
                <pubDate>Wed, 29 Jul 26 07:36:06 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-035099/0001493152-26-035099.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001560/0000897069-26-001560.pdf</link>
                <pubDate>Tue, 28 Jul 26 20:31:41 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001560/0000897069-26-001560.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001558/0000897069-26-001558.pdf</link>
                <pubDate>Tue, 28 Jul 26 20:29:49 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001558/0000897069-26-001558.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001556/0000897069-26-001556.pdf</link>
                <pubDate>Tue, 28 Jul 26 20:28:22 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001556/0000897069-26-001556.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001554/0000897069-26-001554.pdf</link>
                <pubDate>Tue, 28 Jul 26 20:27:01 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0000897069-26-001554/0000897069-26-001554.pdf</guid>
                                                                            </item>
            </channel>
</rss>